Midland-based Dow is eliminating 1,500 jobs around the world as part of a plan to cut $1 billion worth of spending.

Stocks closed lower Wednesday after the Federal Reserve left its key interest rate unchanged amid persistent inflation, as investors prepared for a slew of earnings reports from major technology companies.

P&G is a unique Dividend King because it uses both buybacks and dividends to return capital to shareholders. A Dividend King like Coca-Cola may yield more than P&G, but it doesn't consistently buy back stock.

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Thursday as the stock market digests Big Tech earnings and Fed comments on interest rates.

(Reuters) - Dow missed fourth-quarter profit estimates on Thursday, and said it will lay off 1,500 employees as a part of its $1 billion cost savings plan, as the chemical firm grapples with lackluster demand. Shares were down 2.9% to $39.87 in volatile premarket trade.

Chemical firm Dow missed fourth-quarter profit estimates on Thursday, and said it will lay off 1,500 employees globally.

The Dow Jones fell Wednesday ahead of the Fed interest rate decision and Fed Chair Powell's comments. Meta and Tesla earnings are next.

The Dow Jones sold off Monday as Nvidia stock plunged on an artificial intelligence threat from China known as DeepSeek.

Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend stocks stand out as the best buys right now.

In addition to Olay, P&G said it is innovating in core brands like Pantene and Head and Shoulders, and saw 5% growth in P&G-owned Japanese luxury skincare brand, SK II. P&G attributed the strong performance of SK II to brand building and improved sentiment in China toward Japanese brands.

The US indices look solid in the early hours of Wednesday, a day that will feature the Federal Reserve announcement on interest rates, and monetary policy later in the day.

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's shares had meant it recently ceded that title to French luxury conglomerate LVMH.